Molina Healthcare Stock Plunges on Weak Full-Year Revenue Forecast

Shares of Molina Healthcare (NYSE: MOH) tumbled in pre-market trading after the company issued a full-year revenue forecast that fell significantly short of Wall Street estimates, overshadowing a second-quarter earnings beat.

Revenue Guidance Rattles Investors

Molina reported its second-quarter 2026 results after Wednesday's market close, posting an adjusted earnings per share of $1.51, which surpassed the analyst consensus of approximately $1.39 to $1.40. The company's quarterly revenue of roughly $10.87 billion was largely in line with expectations.

However, investors seized on the company's forward-looking guidance. Molina maintained its full-year 2026 revenue forecast at approximately $42 billion, which is more than $2 billion below the Wall Street consensus of around $44.28 billion. This significant top-line miss triggered the sell-off, with the stock sliding 9.2% in pre-open trading.

Margin Pressures and Membership Decline

Ad

Adding to investor concerns, CEO Joseph Zubretsky characterized 2026 as a "trough year" for Medicaid pretax margins, signaling a period of depressed profitability. The company also pointed to headwinds from Marketplace enrollment pressure and startup costs associated with its new Florida CMS Medicaid contract.

While Molina raised its full-year adjusted EPS guidance to at least $5.25 from a previous floor of $5.00, the improved profit outlook was not enough to offset the revenue concerns. The company's membership also contracted during the quarter, falling to approximately 4.9 million members from 5.0 million in the first quarter.

Market Context

The sharp decline in Molina's stock comes after a period of strong performance leading up to the earnings release, suggesting investors had high expectations. Analyst sentiment had been mixed, with some firms raising price targets in mid-July while others, such as Barclays, had trimmed their targets, citing caution around medical cost pressures and the contraction in Medicaid enrollment affecting the managed care sector.